{{Rsnum
|rsid=2868370
|Gene=HSPB1
|Chromosome=7
|position=76301483
|Orientation=minus
|GMAF=0.1667
|Gene_s=HSPB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 76.9 | 21.5 | 1.5
| HCB | 84.1 | 13.6 | 2.3
| JPT | 57.8 | 35.6 | 6.7
| YRI | 87.3 | 12.7 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 84.1 | 13.6 | 2.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22608953
|Title=HSPB1 Gene Polymorphisms Predict Risk of Mortality for US Patients after Radio(chemo)therapy for Non-Small Cell Lung Cancer
|OA=1
}}{{PMID Auto
|PMID=23374503
|Title=Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.
}}